Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

Completed · Phase 4

Conditions studied: Cystic Fibrosis, Pneumonia, Pseudomonas Aeruginosa Infection

In brief

This study will determine the concentrations of the antibiotic meropenem when administered as a 3 hour prolonged infusion in children with cystic fibrosis who are hospitalized with an acute pulmonary exacerbation. Safety and practicality of administering meropenem as a 3 hour infusion will be measured.

Key facts

Study ID
NCT01429259
Run by
Joseph Kuti
People needed
30
Starts
2012-02-01
Expected to finish
2014-01-01
Last updated by the study team
2018-03-20

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.